Follow
Colm Morrissey
Colm Morrissey
Verified email at uw.edu - Homepage
Title
Cited by
Cited by
Year
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ...
Nature genetics 44 (6), 685-689, 2012
17182012
Inherited DNA-repair gene mutations in men with metastatic prostate cancer
CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ...
New England Journal of Medicine 375 (5), 443-453, 2016
15442016
Quantitative and stoichiometric analysis of the microRNA content of exosomes
JR Chevillet, Q Kang, IK Ruf, HA Briggs, LN Vojtech, SM Hughes, ...
Proceedings of the National Academy of Sciences 111 (41), 14888-14893, 2014
10832014
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent
K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ...
Science 338 (6113), 1465-1469, 2012
9402012
The long tail of oncogenic drivers in prostate cancer
J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ...
Nature genetics 50 (5), 645-651, 2018
7252018
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
A Kumar, I Coleman, C Morrissey, X Zhang, LD True, R Gulati, R Etzioni, ...
Nature medicine 22 (4), 369-378, 2016
6842016
Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling
EG Bluemn, IM Coleman, JM Lucas, RT Coleman, S Hernandez-Lopez, ...
Cancer cell 32 (4), 474-489. e6, 2017
5772017
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis
JM Lucas, C Heinlein, T Kim, SA Hernandez, MS Malik, LD True, ...
Cancer discovery 4 (11), 1310-1325, 2014
4872014
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
A Sharma, WS Yeow, A Ertel, I Coleman, N Clegg, C Thangavel, ...
The Journal of clinical investigation 120 (12), 4478-4492, 2010
3502010
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
A Sharp, I Coleman, W Yuan, C Sprenger, D Dolling, DN Rodrigues, ...
The Journal of clinical investigation 129 (1), 192-208, 2019
3272019
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
A Kumar, TA White, AP MacKenzie, N Clegg, C Lee, RF Dumpit, ...
Proceedings of the National Academy of Sciences 108 (41), 17087-17092, 2011
3042011
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
Nature communications 6 (1), 6170, 2015
2932015
Androgen receptor variants occur frequently in castration resistant prostate cancer metastases
X Zhang, C Morrissey, S Sun, M Ketchandji, PS Nelson, LD True, ...
PloS one 6 (11), e27970, 2011
2922011
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
CC Pritchard, C Morrissey, A Kumar, X Zhang, C Smith, I Coleman, ...
Nature communications 5 (1), 4988, 2014
2802014
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
MP Labrecque, IM Coleman, LG Brown, LD True, L Kollath, B Lakely, ...
The Journal of clinical investigation 129 (10), 4492-4505, 2019
2622019
LuCaP prostate cancer patient‐derived xenografts reflect the molecular heterogeneity of advanced disease and serve as models for evaluating cancer therapeutics
HM Nguyen, RL Vessella, C Morrissey, LG Brown, IM Coleman, ...
The Prostate 77 (6), 654-671, 2017
2542017
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
G Zadra, CF Ribeiro, P Chetta, Y Ho, S Cacciatore, X Gao, S Syamala, ...
Proceedings of the National Academy of Sciences 116 (2), 631-640, 2019
2282019
Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia
HH Cheng, PS Mitchell, EM Kroh, AE Dowell, L Chéry, J Siddiqui, ...
PloS one 8 (7), e69239, 2013
1932013
Combined TP53 and RB1 loss promotes prostate cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress
MD Nyquist, A Corella, I Coleman, N De Sarkar, A Kaipainen, G Ha, ...
Cell reports 31 (8), 2020
1712020
Inter-and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
L Brady, M Kriner, I Coleman, C Morrissey, M Roudier, LD True, R Gulati, ...
Nature communications 12 (1), 1426, 2021
1692021
The system can't perform the operation now. Try again later.
Articles 1–20